Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TSC2 |
Variant | S554L |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | TSC2 S554L does not lie within any known functional domains of the Tsc2 protein (UniProt.org). S554L has been identified in sequencing studies (PMID: 27149842), but has not been biochemically characterized and therefore, its effect on Tsc2 protein function is unknown (PubMed, Oct 2024). |
Associated Drug Resistance | |
Category Variants Paths |
TSC2 mutant TSC2 S554L |
Transcript | NM_000548.5 |
gDNA | chr16:g.2065580C>T |
cDNA | c.1661C>T |
Protein | p.S554L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017023615.1 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001406698.1 | chr16:g.2079667C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
XM_011522636.3 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_000548.5 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
XM_017023616.1 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001370404.1 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001370405.1 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001406690.1 | chr16:g.2079277_2079278delTCinsCT | c.1660_1661delTCinsCT | p.S554L | RefSeq | GRCh38/hg38 |
NM_001406665.1 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001406664.1 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
XM_005255529.4 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
XM_005255531.4 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001406663.1 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
XM_011522639.3 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_021055.3 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
XM_024450413.1 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
XM_011522637.3 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
XM_011522637.2 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
XM_011522636.2 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001363528.2 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001114382.3 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
XM_011522640.2 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001077183.2 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001406692.1 | chr16:g.2079277_2079278delTCinsCT | c.1660_1661delTCinsCT | p.S554L | RefSeq | GRCh38/hg38 |
NM_000548.4 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001406693.1 | chr16:g.2079277_2079278delTCinsCT | c.1660_1661delTCinsCT | p.S554L | RefSeq | GRCh38/hg38 |
NM_001114382.2 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001406694.1 | chr16:g.2079277_2079278delTCinsCT | c.1660_1661delTCinsCT | p.S554L | RefSeq | GRCh38/hg38 |
XM_011522639.2 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001077183.3 | chr16:g.2065580C>T | c.1661C>T | p.S554L | RefSeq | GRCh38/hg38 |
NM_001406689.1 | chr16:g.2079069_2079070delTCinsCT | c.1660_1661delTCinsCT | p.S554L | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|